COVID-19 – an update for our customers
Mervue Laboratories Ireland
As Covid-19 continues to evolve, we want to share what Mervue Laboratories Ireland is doing to ensure the continuity of business and protect the health of our employees, customers, distributors, suppliers and local community.
Firstly, animal health is considered an essential business under Irish government guidelines, so our production and supply chain is running as normal. You can rest assured that, to date, our stock levels are strong and we will continue to monitor them daily with our global distributors.
To ensure the continuation of supply and to safeguard the health of our colleagues, we have introduced a number of measures since the outbreak of the pandemic.
Work schedules are now staggered in our manufacturing facility, social distancing is being adhered to, all workers are following the WHO’s health and hygiene guidance, and all non-essential colleagues are working from home.
Should any Mervue colleague have COVID-19 or suspect exposure to someone with the infection they will self-isolate for 14-days before engaging with customers or colleagues.
We are in regular liaison with our distribution network in over 60 countries to ensure delivery of our vital products is not disrupted for reasons outside of our control. And our production team is working 7 days a week to ensure our customers get their orders on time and in full.
As a company who specialises in cutting edge science and solutions, Mervue Labs is proud to have been the first company in Ireland – in partnership with Irish Distillers, the manufacturers of Jameson – to ensure that our national Health Service Executive (HSE) had supplies of hand sanitiser in early March. We now manufacture over 40,000 units of GelGuard hand gel per day and are the primary supplier to the HSE, Irish Defence forces, Tusla and the Department of Welfare to name just a few of the key frontline services we provide protection to. This week, we are producing our one-millionth bottle.
In addition to prioritizing the safety of our country, supply chain, customers and colleagues, we are also monitoring the potential impact of coronavirus on pets and animals. The WHO advises that there is no current evidence that animals or pets can spread the virus.
Despite the challenges that Covid-19 presents, it is business as normal here at Mervue. Our R&D team continue to develop exciting new nutraceutical products, which we look forward to launching in the coming months.
Please get in touch if you have any queries. Our customer service and product support teams are available to answer any of your questions.
Thank you for your valued support. We hope that you, your families and employees stay safe and well.
Martin Beirne and William Twomey
Directors at Mervue Laboratories